NCT00148759View on ClinicalTrials.gov

Kaletra Sex/Gender Pharmacokinetics (PK) Study

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
HIV Infections
Interventions
DRUG

LPV/r

LPV/r 800/200 mg once daily

Trial Locations (1)

30308

Grady Infectious Diseases Program, Atlanta

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Emory University

OTHER